193 related articles for article (PubMed ID: 22449653)
1. Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activity.
Rasolofonjatovo E; Provot O; Hamze A; Rodrigo J; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Brion JD; Alami M
Eur J Med Chem; 2012 Jun; 52():22-32. PubMed ID: 22449653
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents.
Liu J; Zheng CH; Ren XH; Zhou F; Li W; Zhu J; Lv JG; Zhou YJ
J Med Chem; 2012 Jun; 55(12):5720-33. PubMed ID: 22676247
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.
Kamal A; Kumar GB; Vishnuvardhan MV; Shaik AB; Reddy VS; Mahesh R; Sayeeda IB; Kapure JS
Org Biomol Chem; 2015 Apr; 13(13):3963-81. PubMed ID: 25721862
[TBL] [Abstract][Full Text] [Related]
4. Discovery of isoerianin analogues as promising anticancer agents.
Messaoudi S; Hamze A; Provot O; Tréguier B; Rodrigo De Losada J; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
ChemMedChem; 2011 Mar; 6(3):488-97. PubMed ID: 21360820
[TBL] [Abstract][Full Text] [Related]
5. Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent.
Messaoudi S; Tréguier B; Hamze A; Provot O; Peyrat JF; De Losada JR; Liu JM; Bignon J; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
J Med Chem; 2009 Jul; 52(14):4538-42. PubMed ID: 19530698
[TBL] [Abstract][Full Text] [Related]
6. B-ring-modified isocombretastatin A-4 analogues endowed with interesting anticancer activities.
Hamze A; Rasolofonjatovo E; Provot O; Mousset C; Veau D; Rodrigo J; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
ChemMedChem; 2011 Dec; 6(12):2179-91. PubMed ID: 21990101
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
Qian Y; Zhang HJ; Lv PC; Zhu HL
Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
10. IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity.
Soussi MA; Provot O; Bernadat G; Bignon J; Desravines D; Dubois J; Brion JD; Messaoudi S; Alami M
ChemMedChem; 2015 Aug; 10(8):1392-402. PubMed ID: 26076053
[TBL] [Abstract][Full Text] [Related]
11. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M; Maya AB; Pérez-Melero C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Chiang YK; Lai MJ; Yeh JY; Wu SY; Chang JY; Liou JP; Hsieh HP
J Med Chem; 2008 Dec; 51(24):8163-7. PubMed ID: 19053773
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.
Prakasham AP; Saxena AK; Luqman S; Chanda D; Kaur T; Gupta A; Yadav DK; Chanotiya CS; Shanker K; Khan F; Negi AS
Bioorg Med Chem; 2012 May; 20(9):3049-57. PubMed ID: 22472045
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
18. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY
J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
